The evaluation of the possibility of Li-Fraumeni syndrome in cancer patients in East Azarbaijan Province of Iran

References

• Mai, P. L.; Malkin, D.; Garber, J. E.; Schiffman, J. D.; Weitzel, J. N.; Strong, L. C.; Wyss, O.; Locke, L.; Means, V.; Achatz, M. I.; et al. Li-Fraumeni Syndrome: Report of a Clinical Research Workshop and Creation of a Research Consortium. Cancer Genet. 2012, 205, 479–487. DOI: 10.1016/j.cancergen.2012.06.008.
   PubMed Web of Science ®Google Scholar
• Bougeard, G.; Renaux-Petel, M.; Flaman, J.-M.; Charbonnier, C.; Fermey, P.; Belotti, M.; Gauthier-Villars, M.; Stoppa-Lyonnet, D.; Consolino, E.; Brugières, L.; et al. Revisiting Li-Fraumeni Syndrome from TP53 Mutation Carriers. J. Clin. Oncol. 2015, 33, 2345–2352. ‏ DOI: 10.1200/JCO.2014.59.5728.
   PubMed Web of Science ®Google Scholar
• Hainaut, P.; Pfeifer, G. P. Somatic TP53 Mutations in the Era of Genome Sequencing. Cold Spring Harb. Perspect. Med. 2016, 6, a026179. DOI: 10.1101/cshperspect.a026179.
   PubMed Web of Science ®Google Scholar
• Guha, T.; Malkin, D. Inherited TP53 Mutations and the Li–Fraumeni Syndrome. Cold Spring Harb. Perspect. Med. 2017, 7, a026187. DOI: 10.1101/cshperspect.a026187.
   PubMed Web of Science ®Google Scholar
• Dickson, B. C. Li–Fraumeni Syndrome: A Role for Surgical Pathologists? Diagnostic Histopathol. 2012, 18, 177–184. DOI: 10.1016/j.mpdhp.2012.01.003.
   Google Scholar
• Correa, H. Li-Fraumeni Syndrome. J. Pediatr. Genet. 2016, 5, 84–88.
   PubMed Web of Science ®Google Scholar
• Malkin, D. Li–Fraumeni Syndrome. Adrenocortical Carcinoma. 2009, 173–191. DOI: 10.1007/978-0-387-77236-3_11.
   Google Scholar
• Kwong, A.; Yvonne Shin, V.; Y. S.; Ho C, Au, C. H.; P.; Slavin T, N.; Weitzel J, Chan, T. L.; S. K.; Ma, E. Mutation Screening of Germline TP53 Mutations in High-Risk Chinese Breast Cancer Patients. BMC Cancer. 2020, 20, 1053. DOI: 10.1186/s12885-020-07476-y.
   PubMedGoogle Scholar
• Yurgelun, M. B.; Masciari, S.; Joshi, V. A.; Mercado, R. C.; Lindor, N. M.; Gallinger, S.; Hopper, J. L.; Mark, A. J.; Buchanan, D. D.; Newcomb, P. A.; et al. Germline TP53 Mutations in Patients with Early-Onset Colorectal Cancer in the Colon Cancer Family Registry. JAMA Oncol. 2015, 1, 214–221. DOI: 10.1001/jamaoncol.2015.0197.
   PubMed Web of Science ®Google Scholar
• Gonzalez, K. D.; Noltner, K. A.; Buzin, C. H.; Gu, D.; Wen-Fong, C. Y.; Nguyen, V. Q.; Han, J. H.; Lowstuter, K.; Longmate, J.; Sommer, S. S.; Weitzel, J. N. Beyond Li Fraumeni Syndrome: Clinical Characteristics of Families with p53 Germline Mutations. J. Clin. Oncol. 2009, 27, 1250–1256. DOI: 10.1200/JCO.2008.16.6959.
   PubMed Web of Science ®Google Scholar
• Masciari, S.; Dewanwala, A.; Stoffel, E. M.; Lauwers, G. Y.; Zheng, H.; Achatz, M. I.; Riegert-Johnson, D.; Foretova, L.; Silva, E. M.; Digianni, L.; et al. Gastric Cancer in Individuals with Li-Fraumeni Syndrome. Genet. Med. 2011, 13, 651–657. DOI: 10.1097/GIM.0b013e31821628b6.
   PubMed Web of Science ®Google Scholar
• Giacomazzi, J.; Graudenz, M. S.; Osorio, C. A.; Koehler-Santos, P.; Palmero, E. I.; Zagonel-Oliveira, M.; Michelli, R. A. D.; Neto, C. S.; Fernandes, G. C.; Achatz, M. I.; et al. Prevalence of the TP53 p. R337H Mutation in Breast Cancer Patients in Brazil. PLoS One. 2014, 9, e99893. DOI: 10.1371/journal.pone.0099893.
   PubMed Web of Science ®Google Scholar
• Bouaoun, L.; Sonkin, D.; Ardin, M.; Hollstein, M.; Byrnes, G.; Zavadil, J.; Olivier, M. TP53 Variations in Human Cancers: New Lessons from the IARC TP53 Database and Genomics Data. Hum. Mutat. 2016, 37, 865–876. ‏ DOI: 10.1002/humu.23035.
   PubMed Web of Science ®Google Scholar
• Govindasamy, P.; Sharchil, C.; Mohan, N.; Pandurangan, P.; Tarigopula, A.; Mani, R.; Samuel, C. R. TP53 Gene Alterations Including Codon 72 Polymorphism in Patients with Multiple Myeloma. J. Clinical Diagnostic Res. 2018, 12, 1–5.
   Web of Science ®Google Scholar
• Dehghan, R.; Hosseinpour Feizi, M. A.; Pouladi, N.; Adampourezare, M.; Farajzadeh, D. The TP53 Intron 6 G13964C Polymorphism and Risk of Thyroid and Breast Cancer Development in the Iranian Azeri Population. Asian Pac. J. Cancer Prev. 2015, 16, 3073–3077. DOI: 10.7314/apjcp.2015.16.7.3073.
   PubMedGoogle Scholar
• Billant, O.; Blondel, M.; Voisset, C. p53, p63 and p73 in the Wonderland of S. cerevisiae. Oncotarget. 2017, 8, 57855–57869. DOI: 10.18632/oncotarget.18506.
   PubMedGoogle Scholar
• Basu, S.; Murphy, M. E. Genetic Modifiers of the p53 Pathway. Cold Spring Harb. Perspect. Med. 2016, 6, a026302. DOI: 10.1101/cshperspect.a026302.
   PubMed Web of Science ®Google Scholar
• Giacomazzi, C. R.; Giacomazzi, J.; Netto, C. B.; Santos-Silva, P.; Selistre, S. G.; Maia, A. L.; Oliveira, V. Z. D.; Camey, S. A.; Goldim, J. R.; Ashton-Prolla, P. Pediatric Cancer and Li-Fraumeni/Li-Fraumeni-like Syndromes: A Review for the Pediatrician. Rev. Assoc. Med. Bras. (1992). 2015, 61, 282–289. DOI: 10.1590/1806-9282.61.03.282.
   PubMed Web of Science ®Google Scholar
• Kaatsch, P. Epidemiology of Childhood Cancer. Cancer Treatment Rev. 2010, 36, 277–285. DOI: 10.1016/j.ctrv.2010.02.003.
   PubMed Web of Science ®Google Scholar
• Moradi, A.; Semnani, S.; Roshandel, G.; Mirbehbehani, N.; Keshtkar, A.; Aarabi, M.; Moghaddami, A.; Cheraghali, F. Incidence of Childhood Cancers in Golestan Province of Iran. Iran. J. Pediat. 2010, 20, 335.
   PubMed Web of Science ®Google Scholar
• Spallek, J.; Spix, C.; Zeeb, H.; Kaatsch, P.; Razum, O. Cancer Patterns among Children of Turkish Descent in Germany: A Study at the German Childhood Cancer Registry. BMC Public Health. 2008, 8, 152. DOI: 10.1186/1471-2458-8-152.
   PubMed Web of Science ®Google Scholar
• Fathi, A.; Bahadoram, M.; Amani, F. Epidemiology of Childhood Cancer in Northwest Iran. Asian Pac. J. Cancer Prev. 2015, 16, 5459–5462. DOI: 10.7314/apjcp.2015.16.13.5459.
   PubMedGoogle Scholar
• McIntyre, J. F.; Smith-Sorensen, B.; Friend, S. H.; Kassell, J.; Borresen, A.-L.; Yan, Y. X.; Russo, C.; Sato, J.; Barbier, N.; Miser, J. Germline Mutations of the p53 Tumor Suppressor Gene in Children with Osteosarcoma. J. Clin. Oncol. 1994, 12, 925–930. DOI: 10.1200/JCO.1994.12.5.925.
   PubMed Web of Science ®Google Scholar
• Wasserman, J. D.; Novokmet, A.; Eichler-Jonsson, C.; Ribeiro, R. C.; Rodriguez-Galindo, C.; Zambetti, G. P.; Malkin, D. Prevalence and Functional Consequence of TP53 Mutations in Pediatric Adrenocortical Carcinoma: A Children’s Oncology Group Study. J. Clin. Oncol. 2015, 33, 602–609. DOI: 10.1200/JCO.2013.52.6863.
   PubMed Web of Science ®Google Scholar
• Klumb, C. E. N. P.; Resende, L.; Tajara, E. H.; Bertelli, E. C. P.; Rumjanek, V. M.; Maia, R. C. p53 Gene Analysis in Childhood B non-Hodgkin’s Lymphoma. Sao Paulo Med. J. 2001, 119, 212–215. DOI: 10.1590/s1516-31802001000600006.
   PubMedGoogle Scholar
• Blau, O.; Avigad, S.; Stark, B.; Kodman, Y.; Luria, D.; Cohen, I. J.; Zaizov, R. Exon 5 Mutations in the p53 Gene in Relapsed Childhood Acute Lymphoblastic Leukemia. Leuk. Res. 1997, 21, 721–729. DOI: 10.1016/s0145-2126(97)80032-x.
   PubMed Web of Science ®Google Scholar